Our data also suggest that even tumors with aberrations in both alleles of POLE (‘double hit’-phenotype) or double mutations of POLE do not necessarily differ from counterparts with wildtype alleles or with a mutation in one allele with respect to clinical features of the tumor. This evidence concerns the gene POLE and neoplasm.